Eisai
4523.T
#2171
Rank
A$12.14 B
Marketcap
A$43.08
Share price
2.53%
Change (1 day)
-4.22%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.22. an increase over its 2024 EPS that were of A$1.37.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.5411.85%
2024A$1.37-32.63%
2023A$2.045.52%
2022A$1.93-74.01%
2021A$7.44-66.58%
2020A$22.2698.24%
2019A$11.2317.01%
2018A$9.6037.78%
2017A$6.97-27.62%
2016A$9.6235.33%
2015A$7.11-2.82%
2014A$7.32-27.66%
2013A$10.12-27.49%
2012A$13.95-12.67%
2011A$15.9888.08%
2010A$8.49-11.06%
2009A$9.55-390.15%
2008A-$3.29-127.78%
2007A$11.8511.78%
2006A$10.604.38%
2005A$10.167.4%
2004A$9.4643.03%
2003A$6.6125.09%
2002A$5.2952.67%
2001A$3.4669.76%
2000A$2.04